Communications medicine · 2025
Unveiling proteomic and peptide-level modifications in cerebrospinal fluid and plasma in normal cognitive aging.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kamalian Aida, Shichkova Polina, Tognetti Marco, Below Christopher, Ho Sara G, Bruderer Roland, Reiter Lukas, Feng Yuehan, Lutz Michael W, Moghekar Abhay
Аннотация
BACKGROUND: Normal cognitive aging is accompanied by molecular changes in the brain and periphery, but the specific proteomic and peptide-level alterations remain poorly defined. This study aimed to characterize age-related protein and peptide modifications by analyzing matched cerebrospinal fluid (CSF) and plasma samples from cognitively normal individuals.
METHODS: Mass spectrometry was used to profile the proteome and peptide-level data of CSF and plasma samples from young (n = 52; mean age 29 ± 5.9 years; 4% male) and older (n = 40; mean age 69 ± 6.3 years; 48% male) adults. Differential abundance analysis, gene set enrichment, and weighted correlation network analyses were performed to identify age-associated pathways. Protein cleavage, alternative splicing, and phosphorylation events were examined to capture post-translational modifications linked to aging.
RESULTS: In CSF, aging is associated with significant upregulation of extracellular matrix (ECM) components, coagulation, and inflammatory pathways. In plasma, the insulin-like growth factor-1 (IGF-1) signaling pathway is notably downregulated. Peptide-level analysis reveals novel alternative cleavage and phosphorylation patterns in key proteins involved in lipid metabolism, ECM structure, axonogenesis, and synaptic activity, including APP, APOE, COL4A2, NRXN1, and NRCAM. These findings highlight distinct and compartment-specific molecular changes that occur with aging.
CONCLUSIONS: This study provides a comprehensive proteomic and peptide-level landscape of normal cognitive aging, identifying both protein-level shifts and novel age-associated cleavage and phosphorylation events.
METHODS: Mass spectrometry was used to profile the proteome and peptide-level data of CSF and plasma samples from young (n = 52; mean age 29 ± 5.9 years; 4% male) and older (n = 40; mean age 69 ± 6.3 years; 48% male) adults. Differential abundance analysis, gene set enrichment, and weighted correlation network analyses were performed to identify age-associated pathways. Protein cleavage, alternative splicing, and phosphorylation events were examined to capture post-translational modifications linked to aging.
RESULTS: In CSF, aging is associated with significant upregulation of extracellular matrix (ECM) components, coagulation, and inflammatory pathways. In plasma, the insulin-like growth factor-1 (IGF-1) signaling pathway is notably downregulated. Peptide-level analysis reveals novel alternative cleavage and phosphorylation patterns in key proteins involved in lipid metabolism, ECM structure, axonogenesis, and synaptic activity, including APP, APOE, COL4A2, NRXN1, and NRCAM. These findings highlight distinct and compartment-specific molecular changes that occur with aging.
CONCLUSIONS: This study provides a comprehensive proteomic and peptide-level landscape of normal cognitive aging, identifying both protein-level shifts and novel age-associated cleavage and phosphorylation events.